Technical Analysis for ASNS - Arsanis, Inc.

Grade Last Price % Change Price Change
grade F 3.17 6.38% 0.19
ASNS closed up 6.38 percent on Thursday, July 19, 2018, on 1.6 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Aug 9

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical ASNS trend table...

Date Alert Name Type % Chg
Jul 19 Slingshot Bearish Bearish Swing Setup 0.00%
Jul 19 MACD Bullish Signal Line Cross Bullish 0.00%
Jul 19 Narrow Range Bar Range Contraction 0.00%
Jul 19 Wide Bands Range Expansion 0.00%
Jul 19 Oversold Stochastic Weakness 0.00%
Jul 18 New 52 Week Closing Low Bearish 6.38%
Jul 18 Narrow Range Bar Range Contraction 6.38%
Jul 18 New 52 Week Low Weakness 6.38%
Jul 18 Wide Bands Range Expansion 6.38%
Jul 18 Down 3 Days in a Row Weakness 6.38%

Older signals for ASNS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Arsanis, Inc. is a United States-based company engaged in the discovery and development of monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company's mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and ASN500. Its lead program, ASN100, is being studied to prevent hospital-acquired Staphylococcus aureus pneumonia in mechanically ventilated patients heavily colonized with Staphylococcus aureus in their respiratory tracts. Its ASN200 addresses the unmet medical need caused by drug-resistant extra-intestinal escherichia coli infections. Its ASN300 addresses the unmet medical need due to carbapenem-resistant klebsiella pneumoniae infections. Its ASN400 addresses the unmet medical need due to streptococcus pneumoniae, a leading cause of mortality among the elderly. The ASN500 program consisting of potent mAbs targeting respiratory syncytial virus (RSV), is in the discovery phase.
Is ASNS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.69
52 Week Low 2.94
Average Volume 107,742
200-Day Moving Average 0.0
50-Day Moving Average 13.5924
20-Day Moving Average 7.1525
10-Day Moving Average 3.381
Average True Range 1.036
ADX 44.76
+DI 11.5222
-DI 44.8349
Chandelier Exit (Long, 3 ATRs ) 15.882
Chandelier Exit (Short, 3 ATRs ) 6.048
Upper Bollinger Band 19.7203
Lower Bollinger Band -5.4153
Percent B (%b) 0.34
BandWidth 351.423978
MACD Line -3.4161
MACD Signal Line -3.4739
MACD Histogram 0.0578
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.53
Resistance 3 (R3) 3.51 3.38 3.47
Resistance 2 (R2) 3.38 3.28 3.39 3.45
Resistance 1 (R1) 3.27 3.23 3.33 3.29 3.43
Pivot Point 3.14 3.14 3.16 3.15 3.14
Support 1 (S1) 3.03 3.04 3.09 3.05 2.91
Support 2 (S2) 2.90 2.99 2.91 2.89
Support 3 (S3) 2.79 2.90 2.87
Support 4 (S4) 2.81